Yoland Smith Selected Research

Huntington Disease (Huntington's Disease)

1/2019	Striatal Interneurons in Transgenic Nonhuman Primate Model of Huntington's Disease.
1/2015	Progressive cognitive deficit, motor impairment and striatal pathology in a transgenic Huntington disease monkey model from infancy to adulthood.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoland Smith Research Topics

Disease

26	Parkinson Disease (Parkinson's Disease) 03/2023 - 01/2006
13	Parkinsonian Disorders (Parkinsonism) 10/2021 - 06/2007
4	Dystonia (Limb Dystonia) 12/2023 - 06/2013
4	Dyskinesias (Dyskinesia) 11/2019 - 04/2008
3	Nervous System Diseases (Neurological Disorders) 12/2015 - 02/2009
3	Schizophrenia (Dementia Praecox) 01/2013 - 12/2011
2	Dystonia musculorum deformans type 1 12/2023 - 06/2013
2	Seizures (Absence Seizure) 02/2023 - 05/2007
2	Status Epilepticus (Complex Partial Status Epilepticus) 02/2023 - 10/2006
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 02/2015
2	Inflammation (Inflammations) 10/2020 - 07/2014
2	Huntington Disease (Huntington's Disease) 01/2019 - 01/2015
2	Cognitive Dysfunction 01/2019 - 01/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 03/2009
2	Brain Diseases (Brain Disorder) 12/2016 - 09/2015
2	Dystonic Disorders (Writer's Cramp) 10/2015 - 06/2013
2	Substance-Related Disorders (Drug Abuse) 09/2015 - 02/2007
1	Amyloid angiopathy 01/2022
1	Hydrocephalus (Hydrocephaly) 01/2017
1	Disease Progression 07/2015
1	Movement Disorders (Movement Disorder) 01/2014
1	Rett Syndrome (Rett's Disorder) 01/2013
1	Mental Disorders (Mental Disorder) 01/2012
1	Catalepsy 11/2011
1	Body Weight (Weight, Body) 07/2011
1	Basal Ganglia Diseases (Basal Ganglia Disease) 01/2011
1	Epilepsy (Aura) 10/2006

Drug/Important Bio-Agent (IBA)

17	Dopamine (Intropin)FDA LinkGeneric 12/2023 - 04/2006
11	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2020 - 06/2007
7	Levodopa (L Dopa)FDA LinkGeneric 01/2023 - 04/2008
6	Proteins (Proteins, Gene)FDA Link 02/2023 - 03/2009
3	DysbindinIBA 01/2013 - 12/2011
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2018 - 02/2007
2	Cholinergic Agents (Cholinergics)IBA 01/2018 - 09/2015
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2015 - 02/2015
2	Dopamine Agonists (Dopamine Agonist)IBA 10/2015 - 03/2010
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 07/2014 - 02/2012
2	gamma-Aminobutyric Acid (GABA)IBA 08/2012 - 04/2006
2	Therapeutic UsesIBA 02/2012 - 02/2009
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 12/2023
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2023
1	Kainic Acid (Kainate)IBA 02/2023
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Tumor Necrosis Factor InhibitorsIBA 10/2020
1	XENP 1595IBA 10/2020
1	GuanineIBA 01/2019
1	Cysteine (L-Cysteine)FDA Link 01/2019
1	Adenine FDA LinkGeneric 01/2019
1	polyglutamineIBA 01/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2018
1	sodium-hydrogen exchanger regulatory factorIBA 01/2017
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2017
1	metabotropic glutamate receptor 4IBA 12/2016
1	Dopamine AntagonistsIBA 10/2015
1	Trihexyphenidyl (Artane)FDA LinkGeneric 10/2015
1	Cholinergic ReceptorsIBA 09/2015
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	Green Fluorescent ProteinsIBA 07/2014
1	Adenosine A2 Receptor AntagonistsIBA 07/2014
1	Codon (Codons)IBA 06/2013
1	GATIBA 08/2012
1	EnzymesIBA 03/2012
1	PeroxiredoxinsIBA 03/2012
1	AntioxidantsIBA 03/2012
1	Haloperidol (Haldol)FDA LinkGeneric 11/2011
1	Metabotropic Glutamate 5 ReceptorIBA 07/2011
1	PyrrolidinesIBA 07/2011
1	pyridineIBA 07/2011
1	Vesicular Glutamate Transport Protein 1IBA 04/2011
1	Ionotropic Glutamate ReceptorsIBA 01/2011
1	LigandsIBA 12/2010
1	2- carbomethoxy- 3- (4- chlorophenyl)- 8- (2- fluoroethyl)nortropaneIBA 12/2010
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 12/2010
1	metabotropic glutamate receptor type 1IBA 06/2007
1	Messenger RNA (mRNA)IBA 05/2007
1	Anticonvulsants (Antiepileptic Drugs)IBA 05/2007
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 05/2007
1	Pilocarpine (Ocusert)FDA LinkGeneric 10/2006

Therapy/Procedure

8	Therapeutics 01/2018 - 09/2007
5	Denervation 10/2021 - 02/2009
2	Deep Brain Stimulation 01/2014 - 11/2013
2	Injections 07/2011 - 12/2010
2	Drug Therapy (Chemotherapy) 01/2011 - 01/2006
1	Ketogenic Diet 05/2007